Abnormal_JJ
regulation_NN
of_IN
the_DT
IL-2_NN
promoter_NN
in_IN
lpr_NN
CD4-CD8_NN
-_:
T_NN
lymphocytes_NNS
results_VBZ
in_IN
constitutive_JJ
expression_NN
of_IN
a_DT
novel_JJ
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells-binding_JJ
factor_NN
._.

The_DT
inert_JJ
quality_NN
of_IN
MRL-Ipr\/Ipr_NN
-LRB-_-LRB-
Ipr_NN
-RRB-_-RRB-
peripheral_JJ
CD4-CD8_NN
-_:
-LRB-_-LRB-
CD4-8_NN
-_NN
-RRB-_-RRB-
T_NN
cells_NNS
manifests_VBZ
primarily_RB
as_IN
an_DT
inability_NN
to_TO
proliferate_VB
or_CC
produce_VB
IL-2_NN
in_IN
response_NN
to_TO
TCR_NN
or_CC
mitogenic_JJ
stimulation_NN
._.

Yet_RB
these_DT
same_JJ
cells_NNS
do_VBP
initiate_VB
early_JJ
TCR-mediated_JJ
signaling_NN
events_NNS
,_,
such_JJ
as_IN
generation_NN
of_IN
inositol_NN
phosphates_NNS
and_CC
increased_VBN
intracellular_JJ
calcium_NN
._.

They_PRP
also_RB
display_VBP
constitutively_RB
high_JJ
levels_NNS
of_IN
p59fyn_NN
and_CC
CD3_NN
zeta_NN
tyrosine_NN
phosphorylation_NN
._.

The_DT
generation_NN
of_IN
second_JJ
messengers_NNS
in_IN
T_NN
cells_NNS
normally_RB
leads_VBZ
to_TO
downstream_JJ
signaling_NN
that_WDT
results_VBZ
in_IN
transcriptional_JJ
activation_NN
of_IN
the_DT
IL-2_NN
gene_NN
._.

We_PRP
,_,
therefore_RB
,_,
compared_VBD
the_DT
activation_NN
state_NN
of_IN
the_DT
IL-2_NN
gene_NN
promoter_NN
region_NN
in_IN
freshly_RB
isolated_VBN
and_CC
stimulated_VBN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
with_IN
that_DT
of_IN
normal_JJ
T_NN
lymphocytes_NNS
._.

Levels_NNS
of_IN
the_DT
octamer_NN
,_,
NF-kappa_NN
B_NN
-LRB-_-LRB-
p50-p65_NN
heterodimer_NN
-RRB-_-RRB-
,_,
and_CC
AP-1_NN
transcriptional_JJ
factors_NNS
are_VBP
constitutively_RB
elevated_VBN
in_IN
freshly_RB
isolated_VBN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
,_,
consistent_JJ
with_IN
the_DT
activated_VBN
phenotype_NN
of_IN
these_DT
cells_NNS
._.

Upon_IN
stimulation_NN
with_IN
mitogens_NNS
,_,
formation_NN
of_IN
the_DT
transactivating_VBG
complex_NN
,_,
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
,_,
occurs_VBZ
with_IN
normal_JJ
kinetics_NNS
in_IN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
._.

Yet_RB
,_,
the_DT
levels_NNS
of_IN
the_DT
activating_VBG
NF-AT_NN
complex_NN
never_RB
reach_VBP
those_DT
observed_VBN
in_IN
similarly_RB
stimulated_VBN
normal_JJ
T_NN
cells_NNS
._.

Furthermore_RB
,_,
nuclear_JJ
extracts_NNS
from_IN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
display_VBP
high_JJ
levels_NNS
of_IN
a_DT
novel_JJ
specific_JJ
binding_NN
activity_NN
at_IN
the_DT
NF-AT_NN
site_NN
,_,
which_WDT
is_VBZ
present_JJ
at_IN
much_RB
lower_JJR
levels_NNS
in_IN
freshly_RB
isolated_VBN
normal_JJ
T_NN
lymphocytes_NNS
._.

Upon_IN
mitogenic_JJ
stimulation_NN
,_,
the_DT
binding_VBG
activity_NN
of_IN
the_DT
novel_JJ
NF-AT-binding_JJ
factor_NN
is_VBZ
rapidly_RB
down-regulated_VBN
in_IN
normal_JJ
T_NN
cells_NNS
,_,
but_CC
persists_VBZ
at_IN
high_JJ
levels_NNS
in_IN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
._.

These_DT
two_CD
abnormalities_NNS
at_IN
the_DT
NF-AT_NN
site_NN
provide_VBP
a_DT
potential_JJ
mechanism_NN
to_TO
account_VB
for_IN
the_DT
defect_NN
in_IN
IL-2_NN
production_NN
from_IN
Ipr_NN
CD4-8_NN
-_:
T_NN
cells_NNS
._.

